Journal of Andrology, Vol 21, Issue 3 464-469, Copyright © 2000 by The American Society of Andrology

JOURNAL ARTICLE

Mechanism of protection of rat spermatogenesis by hormonal pretreatment: stimulation of spermatogonial differentiation after irradiation

M. L. Meistrich, G. Wilson, M. Kangasniemi and I. Huhtaniemi
Department of Experimental Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. meistrich@odin.mdacc.tmc.edu

Pretreatment of rats with hormones that suppress testosterone levels and sperm production enhances the recovery of spermatogenesis from stem cells after a cytotoxic insult. It is not known whether the enhanced recovery results from an increase in the numbers of surviving stem cells or whether their ability to differentiate is enhanced. In this study, untreated rats and rats pretreated with testosterone plus estradiol-17beta (T + E) were irradiated with 3.5 or 6 Gy, and the recovery of spermatogenesis from surviving stem cells was assessed at 6, 10, and 20 weeks after irradiation. T + E pretreatment did not significantly affect the numbers of A spermatogonia remaining in the tubules at 6 weeks after irradiation. In rats that were given irradiation alone, spermatogenesis steadily declined after 6 weeks because the stem cells lost their ability to differentiate. However, when rats were treated with T + E before irradiation, this decline was prevented, and in fact, at least at the lower dose of radiation, there was a progressive recovery of spermatogenesis. Given the similar spermatogonial counts at 6 weeks after irradiation in the irradiated-only and T + E-treated, irradiated rats, the hormone treatment appears not to protect stem cells from being killed by the cytotoxic agent. Rather, the later enhancement of spermatogenic recovery results from prevention of an injury-induced change in spermatogonia or in their environment, which would have otherwise resulted in failure of spermatogonial differentiation.

This article has been cited by other articles:

				K. L. Porter, G. Shetty, and M. L. Meistrich Testicular Edema Is Associated with Spermatogonial Arrest in Irradiated Rats Endocrinology, March 1, 2006; 147(3): 1297 - 1305. [Abstract] [Full Text] [PDF]

				K. Boekelheide, H. A. Schoenfeld, S. J. Hall, C. C. Weng, G. Shetty, J. Leith, J. Harper, M. Sigman, D. L. Hess, and M. L. Meistrich Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) Therapy Fails to Protect Nonhuman Primates (Macaca arctoides) From Radiation-Induced Spermatogenic Failure J Androl, March 1, 2005; 26(2): 222 - 234. [Abstract] [Full Text] [PDF]

				G. Shetty and M. L. Meistrich Hormonal Approaches to Preservation and Restoration of Male Fertility After Cancer Treatment J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 36 - 39. [Abstract] [Full Text] [PDF]

				A. Kamischke, H. Jurgens, L. Hertle, W. E. Berdel, and E. Nieschlag Cryopreservation of Sperm From Adolescents and Adults With Malignancies J Androl, July 1, 2004; 25(4): 586 - 592. [Abstract] [Full Text] [PDF]

				M. L. Meistrich and G. Shetty Inhibition of Spermatogonial Differentiation by Testosterone J Androl, March 1, 2003; 24(2): 135 - 148. [Full Text] [PDF]

				C.J.H. Kelnar, C. McKinnell, M. Walker, K.D. Morris, W.H.B. Wallace, P.T.K. Saunders, H.M. Fraser, and R.M. Sharpe Testicular changes during infantile 'quiescence' in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy? Hum. Reprod., May 1, 2002; 17(5): 1367 - 1378. [Abstract] [Full Text] [PDF]

				H. Chiarini-Garcia, J. R. Hornick, M. D. Griswold, and L. D. Russell Distribution of Type A Spermatogonia in the Mouse Is Not Random Biol Reprod, October 1, 2001; 65(4): 1179 - 1185. [Abstract] [Full Text] [PDF]

				S. Ann Hild, M. L. Meistrich, R. P. Blye, and J. R. Reel Lupron Depot Prevention of Antispermatogenic/Antifertility Activity of the Indenopyridine, CDB-4022, in the Rat Biol Reprod, July 1, 2001; 65(1): 165 - 172. [Abstract] [Full Text] [PDF]